Iversen PL - Search Results

1

Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-myc in human prostate cancer cells.

Devi GR, Oldenkamp JR, London CA, Iversen PL. Devi GR, et al. Among authors: iversen pl. Prostate. 2002 Nov 1;53(3):200-10. doi: 10.1002/pros.10151. Prostate. 2002. PMID: 12386920

2

Resistance to chemotherapeutic drugs overcome by c-Myc inhibition in a Lewis lung carcinoma murine model.

Knapp DC, Mata JE, Reddy MT, Devi GR, Iversen PL. Knapp DC, et al. Among authors: iversen pl. Anticancer Drugs. 2003 Jan;14(1):39-47. doi: 10.1097/00001813-200301000-00006. Anticancer Drugs. 2003. PMID: 12544257

3

Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans.

Iversen PL, Arora V, Acker AJ, Mason DH, Devi GR. Iversen PL, et al. Clin Cancer Res. 2003 Jul;9(7):2510-9. Clin Cancer Res. 2003. PMID: 12855625 Clinical Trial.

4

A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.

London CA, Sekhon HS, Arora V, Stein DA, Iversen PL, Devi GR. London CA, et al. Among authors: iversen pl. Cancer Gene Ther. 2003 Nov;10(11):823-32. doi: 10.1038/sj.cgt.7700642. Cancer Gene Ther. 2003. PMID: 14605668

5

X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells.

Amantana A, London CA, Iversen PL, Devi GR. Amantana A, et al. Among authors: iversen pl. Mol Cancer Ther. 2004 Jun;3(6):699-707. Mol Cancer Ther. 2004. PMID: 15210856

6

c-MYC antisense phosphosphorodiamidate morpholino oligomer inhibits lung metastasis in a murine tumor model.

Sekhon HS, London CA, Sekhon M, Iversen PL, Devi GR. Sekhon HS, et al. Among authors: iversen pl. Lung Cancer. 2008 Jun;60(3):347-54. doi: 10.1016/j.lungcan.2007.10.028. Epub 2007 Dec 21. Lung Cancer. 2008. PMID: 18096271

7

Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers.

Ko YJ, Devi GR, London CA, Kayas A, Reddy MT, Iversen PL, Bubley GJ, Balk SP. Ko YJ, et al. Among authors: iversen pl. J Urol. 2004 Sep;172(3):1140-4. doi: 10.1097/01.ju.0000134698.87862.e6. J Urol. 2004. PMID: 15311058

8

Neutrally charged phosphorodiamidate morpholino antisense oligomers: uptake, efficacy and pharmacokinetics.

Arora V, Devi GR, Iversen PL. Arora V, et al. Among authors: iversen pl. Curr Pharm Biotechnol. 2004 Oct;5(5):431-9. doi: 10.2174/1389201043376706. Curr Pharm Biotechnol. 2004. PMID: 15544491

9

In vivo bioavailability and pharmacokinetics of a c-MYC antisense phosphorodiamidate morpholino oligomer, AVI-4126, in solid tumors.

Devi GR, Beer TM, Corless CL, Arora V, Weller DL, Iversen PL. Devi GR, et al. Among authors: iversen pl. Clin Cancer Res. 2005 May 15;11(10):3930-8. doi: 10.1158/1078-0432.CCR-04-2091. Clin Cancer Res. 2005. PMID: 15897595 Clinical Trial.

10

Arginine-rich cell-penetrating peptides facilitate delivery of antisense oligomers into murine leukocytes and alter pre-mRNA splicing.

Marshall NB, Oda SK, London CA, Moulton HM, Iversen PL, Kerkvliet NI, Mourich DV. Marshall NB, et al. Among authors: iversen pl. J Immunol Methods. 2007 Aug 31;325(1-2):114-26. doi: 10.1016/j.jim.2007.06.009. Epub 2007 Jul 27. J Immunol Methods. 2007. PMID: 17673254

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters